Dihydropteridine reductase (QDPR) plays an important role in the recycling of BH4 and is closely related to oxidative stress. We have previously reported that the overexpression of QDPR in human kidney HEK293T cells significantly protected against oxidative stress, and these beneficial effects were abolished by A278C mutation. To evaluate the effect of wild-type and mutant QDPR on autophagy and its mechanism in HEK293T cells, we constructed the wild-type and mutant QDPR expression plasmids and transfected them into HEK293T cells. Three days later, cells were collected to observe the expression of fusion protein and the intracellular production of reactive oxygen species (ROS). Western blot analysis was employed to evaluate the change of mTOR and ribosomal protein S6 kinase B1 (S6K1) signaling and the expression of LC-I, LC-II, Bcl-1, Bcl-2, p62, and p53. The results showed that the exogenous wild-type QDPR significantly decreased the expression of mTOR and phosphorylation of the mTOR and S6K1. Mutation of QDPR inhibited the regulation of mTOR, suggesting that QDPR is a positive regulator of autophagy via suppressing mTOR signaling. The expressions of p62, LC3-II and Beclin 1 were dramatically enhanced in wildtype QDPR group, which were reversed after QDPR mutation. Additionally, mutation of QDPR altered the upregulation of QDPR on Beclin 2. It is therefore concluded that QDPR appears to play an important role in enhancing autophagy, and its mutation contributes to dysregulation of autophagy.
Introduction
Diabetic nephropathy (DN) is a leading cause of end-stage renal disease. Its pathogenesis is complex, and oxidative stress is a critical factor contributing to the progression of this disease. Autophagy is a degradation process that can respond to the rise of cellular oxidative stress, and can be linked to the development of DN [1] .
During the past decade, there has also been an increasing interest in using the processes of autophagy to develop therapeutic strategies for DN. Autophagy is a cellular process that controls cytoplasmic quality by degrading various harmful substrates and it can be associated with the development of many diseases, such as DN [2, 3] . Several important proteins that monitor and regulate autophagy have been identified. Microtubule-associated protein 1 light-chain 3 (LC3) is a protein that is often used to monitor the presence of autophagy [4] , and the level of LC3-II can also be used as a marker to reflect autophagy activity and progression [5] . In addition, mammalian target of rapamycin (mTOR) which functions as an inhibitor of the initiation step of autophagy is also an important signaling pathway used to study autophagy progression [6] . Additionally, autophagy is emerging as an important mediator of pathological responses and engages in cross-talk with reactive oxygen species (ROS). The cross-talk between autophagy and redox signaling is not well understood. Some possibilities include the accumulation of toxic proteins and the decrease in mitochondrial function, leading to further oxidative stress when the autophagic process is disrupted.
Dihydropteridine reductase (QDPR) that maintains the intracellular pool of tetrahydrobiopterin (BH4) plays an important role in the metabolism of nitric oxide synthase (NOS) which can increase nitric oxide (NO) synthesis and scavenge superoxide and peroxynitrite. In our previous study, we verified that the expression of QDPR which function as a free radical scavenger by increasing level of BH4 and attenuating intracellular oxidative stress in DN may inhibit the production of ROS [7] . It was reported that ROS may induce autophagy through regulating the mTOR signaling, and dysregulation of autophagy may contribute to the development of DN [8] . However, the interaction of QDPR with autophagy is unknown.
Here we report the findings in HEK293T cells that QDPR contributes to the dysregulation of autophagy through activation of the mTOR signaling pathway, but this function disappears when QDPR has A278C mutation. Our results suggest that a deficiency in the function of QDPR may contribute to the pathogenesis of DN.
Materials and Methods

Plasmid construction
Polymerase chain reaction (PCR) fragments were amplified with specific primers (forward primer with EcoRV enzyme site: 5′-AGATA TCATGGCGGCTTCGGGCGAGGC-3′; reverse primer with XbaI enzyme site: 5′-ATCTAGAGAAATAGGCTGGAGTAAGCT-3′). The cDNA was extracted from the renal cortex of a normal rat or an OLETF diabetic rat. After amplification, the pCR2.1-T vector was ligated with the QDPR cDNA fragments in accordance with conventional protocols (Invitrogen, Carlsbad, USA). Then, the fusion gene was transformed into DH5α according to the method described by Shah et al. [9] . After that, the QDPR fragments were confirmed by sequence analysis after restriction enzyme digestion ( Supplementary  Fig. S1 ). Finally, the wild-type and mutated fragments were subcloned into pcDNA3.1/V5-His-A vector, respectively, to form recombinant plasmids of rQDPR(wt) and rQDPR(mut).
Cell transfection
First, HEK293T cells were cultured in DMEM (Gibco, Grand Island, USA) containing both 100 U/ml penicillin and 100 μg/ml streptomycin at 37°C. Then, HEK293T cells were seeded at a concentration of 3 × 10 5 cells per well. The recombinant plasmid was transfected into the cells using FuGENE HD transfection reagent (Promega, Madison, USA). The transfection efficiency was detected by epifluorescence inverted microscopy at 24, 48, and 72 h. After 72 h, 80% of cells could express green fluorescent protein (GFP). Control blank vector, rQDPR(wt) and rQDPR(mut) were transfected into the HEK293T cells. Then these cells were collected for further analysis.
BH4 and ROS measurement
Detection of BH4 in cells was carried out with the ELISA method. Cells were collected 72 h after transfection and washed twice with phosphate buffered saline (PBS) at room temperature. Then, BH4 was detected using a BH4 kit (Antibodies-Online, Shanghai, China) as described by the manufacturer. Generation of intracellular ROS level was examined by flow cytometry using an oxidation-sensitive probe. First, cells (3 × 10 5 ) were incubated in a complete medium including 1 mM 2′,7′-dichlorofluorescein diacetate (DCFH-DA; Applygen Technologies, Beijing, China) to allow cellular incorporation for 30 min at 37°C. Then, the cells were gently washed twice with PBS. After that, 10,000 cells per sample were analyzed by inverted fluorescent microscopy (Olympus, Tokyo, Japan).
Western blot analysis
In our study, 60 μg of protein was subject to electrophoresis with 12% SDS-PAGE and transferred to a nylon membrane. The membranes were incubated with primary antibodies at 4°C overnight followed by incubation with appropriate HRP-conjugated secondary antibodies. Anti-LC3, p62, p53, Beclin 1, and Beclin 2 antibodies were purchased from Abcam (Cambridge, USA), anti-p-mTOR, mTOR and p-S6K1 antibodies were from Cell Signaling Technology (Danvers, USA), and anti-β-actin antibody was from Sigma (St Louis, USA). Secondary antibodies were obtained from Invitrogen. The chemiluminescent signals were then developed with standard ECL technique. The bands were quantitated by densitometry and the signals were detected and analyzed using the Image J Analysis software. β-Actin was used for normalization.
Indirect immunofluorescence
To monitor transfection, the cells were incubated with primary antibody against V5 (Invitrogen) in 2% BSA in PBS for 1 h at room temperature after fixation and blocking. After being washed with PBS, the cells were incubated with Alexa Fluor-488-conjugated secondary antibody (1:1000; Invitrogen) for 40 min at room temperature and then mounted using 4′,6-diamidino-2 phenylindole (DAPI)-mounting medium (Invitrogen). The fluorescent signals were collected by confocal fluorescence microscopy (Leica Microsystems, Mannheim, Germany).
Statistical analysis SPSS 16.0 software was used for statistical analysis. Data are expressed as the mean ± SEM. Statistical analysis was performed using Student's t-test, and P < 0.05 was considered of statistically significant difference. Each experiment was performed three times.
Results
Recombinant QDPR expression in cells
Wild-type and mutated QDPR recombinant plasmids carrying the V5 protein were successfully constructed and the correctness of the sequence was confirmed using gene sequencing. During this process, normal (wild-type) and OLETF (point mutation) rat renal cortex were used as the corresponding templates. Finally, wild-type and mutated QDPR were subcloned into pcDNA3.1/V5-His-A vector to form recombinant plasmids.
After transfection of rQDPR(wt), rQDPR(mut), or empty vector (control) into HEK293T cells, the presence of exogenous QDPR was investigated in all groups of cells by immunofluorescence staining with anti-V5 antibody. The results showed that there was a significant elevation of exogenous QDPR protein in cells transfected with either wild-type or mutated QDPR, while no exogenous fusion protein was detected in cells transfected with the empty vector (control). Meanwhile, it is interesting to note that wild-type QDPR was mainly detected in the cytoplasm, but QDPR mutant was detected in the nucleus (Fig. 1) . This finding verified that fusion protein of QDPR was successfully expressed in HEK293T cells and the point mutation changed the structure of QDPR.
Wild-type and mutant QDPR increased BH4 production
The promotion of BH4 recirculation is a major feature of QDPR. To gain insights into the effects of wild-type and mutant QDPR on BH4 production in cells, ELISA was carried out to investigate the difference in BH4 production among these groups. The results showed that the BH4 levels in these three groups of cells were 1.451 ± 0.063 pM, 1.372 ± 0.040 pM, and 0.436 ± 0.007 pM, respectively. Both the wild-type and the mutant QDPR can significantly activate BH4 level in HEK293T cells when compared with the control (P < 0.05). However, there was no difference between the wild-type group and mutant group (P > 0.05). This result demonstrates that QDPR plays an important role in the cycling of BH4, whereas this function is not affected by mutation in QDPR (Fig. 2) . We speculate that this mutation in QDPR may not affect the function of BH4 recirculation.
Mutant QDPR increased ROS generation
To determine whether QDPR is involved in the production of ROS, the generation of ROS was detected in HEK293T cells with exogenous QDPR. The results from flow cytometry showed that ROS levels were significantly increased in the group transfected with mutated QDPR when compared with that of the control. There was no difference between the wild-type group and the control vector group (P > 0.05, Fig. 3 ). These results demonstrated that mutant QDPR can increase ROS production in vitro while wild-type QDPR had no effect on ROS.
Mutant QDPR attenuated wild-type QDPR-induced downregulation of mTOR signaling and p62
Autophagy can become extremely active when ROS generation increases. Therefore, autophagy and ROS are considered as the potential therapeutic targets to slow down the progression of DN. Since ROS were found to be elevated in mutant group, it is possible that QDPR has certain function in response to oxidative stress. Therefore, we further explored whether mTOR signaling is altered by wild-type QDPR overexpression and whether the mediating effect of mTOR after QDPR mutation is affected.
First, the level of mTOR and the phosphorylation of mTOR and S6K1 among these groups were monitored by western blot analysis (Fig. 4A) . Our results showed that overexpression of wild-type QDPR resulted in significantly decreased mTOR (Fig. 4B) , phosphorylation of mTOR (Fig. 4C) and phosphorylation of S6K1 (Fig. 4D) , when compared with that of the control vector group. However, there was no significant difference between the mutant QDPR and the control vector group (P > 0.05, Fig. 4B,D) . Furthermore, the effect of QDPR on autophagy markers (p62 and p53) was examined to verify the relation between ROS and autophagy. As shown in Fig. 4E , p62 was increased in rQDPR(wt) group, indicating that the mechanism through which QDPR regulates autophagy may be associated with the enhanced p62 expression (P < 0.05). Another autophagy marker p53 showed no significant difference among the control vector group, wild-type QDPR group and mutant QDPRgroup (P > 0.05, Fig. 4F ). These results showed that QDPR may regulate autophagy activity in HEK293T cells through p62, which can be reversed by point mutation. Mutant QDPR attenuated wild-type QDPR-induced upregulation of LC3-II and Beclin 1 expression in cells mTOR is known to be a negative regulator of autophagy. As shown above, we demonstrated the function of QDPR in mTOR signaling. To further explore how QDPR suppresses mTOR signaling, the levels of the autophagy markers LC3-I, LC3-II, Beclin 1 and Beclin 2 in cells were assessed by western blot analysis (Fig. 5A) . LC3-I is processed to form LC3-II via lipidation, which allows the insertion of LC3 protein into the autophagosome membrane during autophagy. Our results showed that LC3-II and Beclin 1 were increased significantly in rQDPR(wt) group, while mutant QDPR attenuated wild-type QDPR-induced upregulation of LC3-II and Beclin 1 expression, indicating that basal autophagy is altered in these cells (P < 0.05, Fig. 5B,C) . Additionally, decreased Beclin 2 protein level was found in wild-type QDPR overexpression cells by western blot analysis (Fig. 5D) , suggesting that QDPR mediates Beclin 2 through the mTOR signaling pathway.
Taken together, the observed increase in autophagic activity is consistent with the impairment of mTOR signaling and the profound decrease of LC3-II and Beclin 1 expression in rQDPR(mut) group, suggesting that the effect of QDPR on autophagy is altered after point mutation.
Discussion
The present study was the first to confirm that QDPR plays a role in regulating mTOR signaling and autophagy. Mutation of QDPR leads to deficiency in phosphorylation of S6K1 and increase of LC-II protein levels, demonstrating a regulatory role of QDPR in the mTOR signaling pathway downstream of autophagy.
QDPR which catalyzes the reduction of quinoid dihydropteridine to tetrahydropterine in the presence of NADH or NADPH is considered to have a strong antioxidant activity [10] . QDPR deficiency which is closely related to many diseases is a rare autosomal recessive inherited disease which affects the metabolism of BH4, causing levodoparesponsive parkinsonism, hyperphenylalaninemia and neurotransmitter deficiency [11] . Mutation in the QDPR gene, i.e. NM_000,320 (QDPR) c.68G > A, causes Parkinson's disease (PD), QDPR deficiency and Dopa-Responsive Dystonia (DRD) which are common in the Mediterranean populations [12] . In China, the study of QDPR deficiency is associated with phenylketonuria, and it has been shown that the mutation spectrum of the QDPR gene is different in the Chinese population, while most mutations are related to severe phenotype. Additionally, the mutation spectrum of the QDPR gene has been investigated to determine the effect of mutations on QDPR structure/function and to evaluate the clinical outcome of Chinese patients after treatment [13] . However, there is no report on the lack of QDPR in other diseases. Our previous results demonstrated that QDPR had mutation in the renal cortex of spontaneously diabetic Otsuka Long Evans Tokushima Fatty (OLETF) rats, which suggested a correlation between QDPR and DN. These results showed that the mutation of QDPR may take part in some metabolic diseases and the mechanism is still unknown. QDPR was also found to play a role in reducing TGF-β1 level and oxidative stress when overexpressed in HEK293T cells [14] . Oxidative damage and the associated mitochondrial dysfunction can also influence autophagic activities. As we all known that autophagy is considered as a catabolic pathway that delivers excess, aggregated, or damaged proteins and organelles to lysosomes for degradation. Furthermore, autophagy is upregulated by numerous cellular stressors such as increased levels of ROS. Autophagy plays a very important role in the disease, e.g. autophagy pathway exists in DN [15] . Is there any correlation between QDPR and autophagy? Both wild-type and mutant QDPR can increase the expression of BH4, suggesting that QDPR may regulate autophagy not through the amount of BH4. As mentioned above, QDPR has strong antioxidant activity, but evidence is still insufficient to support that the antioxidant activity of QDPR is associated with BH4. In the current study, we found that overexpression of QDPR reduced the level of ROS, which may regulate the activity of the autophagic process, and mutation of QDPR may result in the increase of ROS in HEK293T cells. Although the mechanism through which ROS regulate autophagy is complex and has not been clarified in detail, p62 and p53 which are regarded as transcriptional sensors of ROS are intimately linked to autophagy [16, 17] . It has been reported that p62 is a scaffolding adaptor implicated in the clearance of protein aggregates by autophagy and is very necessary for cytoprotection under oxidative stress [18] . Increased ROS production in cells may result in elevated expression of microtubule-associated protein 1 light-chain 3 (LC3) and decreased the expression of p62. Our study showed that p62 was elevated in response to ROS in wild-type group, while p62 was decrease of in mutation group. Therefore, QDPR may affect autophagy via regulating p62 expression in response to ROS indirectly. However, QDPR had no effect on p53, so we speculated that autophagy is not regulated by p53 after overexpression of QDPR.
As mentioned above, mTOR (mammalian TOR) functions as an inhibitor of the initiation step of macroautophagy. mTOR is activated and phosphorylated in the presence of growth factors and abundant cellular nutrients. To be precise, phosphorylated mTOR is a sensitive indicator of autophagy. What mediates the phosphorylation of mTOR? Its regulation could be associated with interactions with different populations of protein substrates. For example, mTOR could co-localize with LC3 after autolysosome formation, suggesting that it may regulate autophagosome and lysosome reformation directly [19] . This regulatory step may be subject to ROS-dependent regulation, as mTOR oxidation results in the inhibition of its activity. We monitored mTOR activity by assessing the phosphorylation of its downstream target ribosomal protein S6K1, and the data demonstrated that QDPR inhibited phosphorylation of mTOR and S6K1. This regulation may be related to the changes of p62 and ROS after QDPR overexpression. However, these results should be further confirmed in other cell lines, such as HK-2 cells.
LC3, a representative reflector of cellular autophagy activity, is one of most important autophagosome membrane markers [20] . The mitophagy receptor interacts with LC3 proteins, targeting mitochondria into autophagosomes for degradation. LC3-I undergoes posttranslational modifications to become LC3-II. Of note, LC3-I and LC3-II can be distinguished by their difference in mobility on gel electrophoresis. LC3-II level reflects the relative amount of autophagosomes in the cell. When p62 is available to bind to LC3, the degradation of LC3 can be prevented, thus making LC3 engagement to the autophagosomes possible [21] . Some recent reports showed that lysosomal diseases exhibit an increase in LC3-II, and that p62 is accumulated in autophagosomal accumulation [22, 23] . Besides LC3, Beclin1 was also described as an essential autophagy effector [24, 25] . To verify the regulation of QDPR in autophagy, we constructed wild-type and mutated QDPR plasmids and tranfected them into HEK293T cells. Then, the expressions of autophagy-related LC3-I, LC3-II, and Beclin 1 were measured to observe the effect of QDPR on autophagy. Our results revealed that the protein levels of those genes were upregulated by QDPR overexpression and inhibited by mutant QDPR. Furthermore, wild-type QDPR is mainly expressed in the cytoplasm, while the mutant protein is expressed in the nucleus, which may be related to the change of protein function. The results also showed that QDPR caused the highest conversion of LC3-II from LC3-I and inhibited the phosphorylation of mTOR and S6K. We hypothesize that the mechanism of QDPR involved in the regulation of autophagy is related to the increase of P62 and decrease of ROS.
It is well established that QDPR may involve in the process of autophagy through targeting the ROS-autophagy-apoptosis axis. Additionally, it is suggested that A278C mutation of QDPR destroyed the effects of QDPR on autophagy. However, how QDPR is associated with ROS and autophagy is still not clear, which needs to be explored further.
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